Rocket Lab (NASDAQ: RKLB) has endured a turbulent stretch in 2026, with shares down 36.37% over the past month after peaking at a 52-week high of $151.
The stock now trades around $64.68, sitting well above its 52-week low of $37.57 but reflecting sector rotation and dilution fears tied to the pending $8 billion Iridium acquisition.
Despite the sharp July reset, the underlying fundamentals have continued to strengthen, giving analysts and investors reasons to look past the near-term volatility.
Q1 FY2026 revenue reached $200.35 million, up 63.5% year over year, with an EPS loss of -$0.07 beating the consensus estimate of -$0.0787.
The company’s backlog swelled to $2.2 billion, and on July 21, Rocket Lab secured a $266 million Space Force suborbital launch contract, its largest defense award to date.
Three catalysts are driving the bullish case, starting with meaningful progress on Neutron, the company’s medium-lift reusable rocket targeting a later 2026 debut.
Rocket Lab completed a full-duration burn test of the second-stage AVac engine in mid-July, keeping the Neutron development timeline on track for commercial service entry.
On the defense side, the company was selected for the Golden Dome Space Based Interceptor program alongside Raytheon and holds the $816 million SDA Tracking Layer Tranche 3 contract.
Pentagon spending adds further tailwinds, with FY2027 Space Force procurement including nine Space Development Agency launches as part of a $59.7 billion space-based systems budget.
Citizens reaffirmed a Market Outperform rating with a $130 price target, while Stifel’s Erik Rasmussen maintained a Buy rating at $132.
Bears point to heavy cash burn, with FY2025 free cash flow coming in at -$321.8 million and Q1 alone seeing $450 million raised through an at-the-market offering.
Piper Sandler initiated coverage at Neutral with an $83 target, citing premium valuation concerns, with RKLB trading at a price-to-sales ratio of 54.
Bulls counter that the elevated capital expenditure reflects Neutron infrastructure buildout and integration of the Mynaric, Motiv, and Geost acquisitions, which expand the company’s addressable market.
Compared to peers, Rocket Lab generates more than 13 times AST SpaceMobile’s (NASDAQ: ASTS) quarterly revenue of $14.73 million, at roughly twice the market cap near $16 billion.
Intuitive Machines (NASDAQ: LUNR) posted Q1 2026 revenue of $186.73 million at a $2.56 billion market cap, but lacks a launch platform and the optionality that Neutron represents.
A 24/7 Wall St. price target of $124.43 implies 92.38% upside from current levels, with a bull case scenario pointing to $158.75 if Neutron flies successfully and Iridium closes on schedule.
The bear case target sits at $97.24 if Neutron experiences further delays or Iridium financing encounters unexpected complications.
Price projections extending further out reach $177.79 in 2028, $254.02 in 2029, and $362.94 in 2030, assuming Rocket Lab executes on its Neutron cadence and captures its share of expanding Space Force launch budgets.
The thesis weakens materially if another Neutron delay materializes, if the Iridium deal breaks, or if SDA contract flow slows from its current pace.
For investors comfortable with a 2.55 beta, the record $2.2 billion backlog colliding with the July drawdown presents a setup worth monitoring closely.
